Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)

Compare
46.88
+1.03
+(2.25%)
At close: April 3 at 3:00:02 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,504,986.07
3,504,986.07
4,213,154.57
3,640,800.48
3,299,429.74
Cost of Revenue
1,831,991.28
1,831,991.28
2,273,132.10
2,065,297
1,880,442.69
Gross Profit
1,672,994.79
1,672,994.79
1,940,022.47
1,575,503.48
1,418,987.06
Operating Expense
1,471,572.92
1,471,572.92
1,578,271.82
1,245,497.89
1,182,752.70
Operating Income
201,421.87
201,421.87
361,750.66
330,005.59
236,234.36
Net Non Operating Interest Income Expense
-11,666.17
-11,666.17
-1,087.67
-637.62
-1,923.59
Pretax Income
392,621.47
392,621.47
571,093.50
437,942.96
341,452.92
Tax Provision
24,872.16
24,872.16
47,859.48
31,928.12
35,510.19
Net Income Common Stockholders
362,178.66
362,178.66
521,457.68
408,080.74
305,258.20
Basic EPS
2.79
2.38
3.41
2.68
2.01
Diluted EPS
2.79
2.38
3.41
2.68
2.01
Basic Average Shares
153,318.54
152,175.91
152,920.14
152,268.93
151,869.75
Diluted Average Shares
153,318.54
152,175.91
152,920.14
152,268.93
151,869.75
Total Operating Income as Reported
396,782.58
396,782.58
573,860.30
442,173.08
346,257.97
Rent Expense Supplemental
5,300.08
5,300.08
4,940.71
1,898.47
991.97
Total Expenses
3,303,564.20
3,303,564.20
3,851,403.92
3,310,794.89
3,063,195.38
Net Income from Continuing & Discontinued Operation
362,178.66
362,178.66
521,457.68
408,080.74
305,258.20
Normalized Income
380,034.98
380,034.98
538,048.39
453,968.45
312,632.23
Interest Income
2,344.62
2,344.62
3,732.35
4,961.77
1,784.85
Interest Expense
12,930.54
12,930.54
3,698.59
4,809.25
3,240.26
Net Interest Income
-11,666.17
-11,666.17
-1,087.67
-637.62
-1,923.59
EBIT
405,552.01
405,552.01
574,792.10
442,752.21
344,693.18
EBITDA
446,730.89
446,730.89
615,117.83
481,573.65
378,812.44
Reconciled Cost of Revenue
1,831,991.28
1,831,991.28
2,273,132.10
2,065,297
1,880,442.69
Reconciled Depreciation
41,178.89
41,178.89
40,325.73
38,821.44
34,119.26
Net Income from Continuing Operation Net Minority Interest
362,178.66
362,178.66
521,457.68
408,080.74
305,258.20
Total Unusual Items Excluding Goodwill
-19,064.01
-19,064.01
-18,108.24
-49,496.22
-8,229.91
Total Unusual Items
-19,064.01
-19,064.01
-18,108.24
-49,496.22
-8,229.91
Normalized EBITDA
465,794.90
465,794.90
633,226.07
531,069.86
387,042.35
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,207.68
-1,207.68
-1,517.53
-3,608.51
-855.89
12/31/2021 - 4/19/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade